Page last updated: 2024-08-23

raloxifene hydrochloride and cyclin d1

raloxifene hydrochloride has been researched along with cyclin d1 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fackenthal, JD; Olopade, MD; Olufunmilayo, I	1
Arimoto-Ishida, E; Hisamoto, K; Kurachi, H; Mabuchi, S; Mori, A; Murata, Y; Ohmichi, M; Takahashi, K; Tasaka, K; Tsutsumi, S; Yoshida, M	1
Abe, A; Kawagoe, J; Kurachi, H; Ohmichi, M; Takahashi, K	1
Kong, CZ; Zhang, YX	1
Hoffman, KL; Lerner, SP; Smith, CL	1
Peek, GW; Tollefsbol, TO	1

Reviews

2 review(s) available for raloxifene hydrochloride and cyclin d1

Article	Year
Breast cancer genetics. Implications of clinical practice. Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:3 Topics: Age of Onset; Anticarcinogenic Agents; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Case Management; Cyclin D1; DNA Mutational Analysis; Estrogen Antagonists; Female; Gene Frequency; Genes, BRCA1; Genes, erbB-2; Genetic Counseling; Genetic Testing; Humans; Male; Mammography; Mastectomy; Neoplasm Proteins; Neoplasms, Multiple Primary; Neoplastic Syndromes, Hereditary; Oncogenes; Ovarian Neoplasms; Ovariectomy; Phenotype; Raloxifene Hydrochloride; Retrospective Studies; Risk; Tamoxifen; Transcription Factors	2000
[Cardiovascular effects of SERM]. Clinical calcium, 2004, Volume: 14, Issue:10 Topics: Apoptosis; Cell Cycle; Cyclin D1; Endothelium, Vascular; Estrogens; Gene Expression; Humans; Muscle, Smooth, Vascular; Myocardial Ischemia; Nitric Oxide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Vasodilation	2004

Article

Year

Breast cancer genetics. Implications of clinical practice.

Hematology/oncology clinics of North America, 2000, Volume: 14, Issue:3

Topics: Age of Onset; Anticarcinogenic Agents; BRCA1 Protein; BRCA2 Protein; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma; Case Management; Cyclin D1; DNA Mutational Analysis; Estrogen Antagonists; Female; Gene Frequency; Genes, BRCA1; Genes, erbB-2; Genetic Counseling; Genetic Testing; Humans; Male; Mammography; Mastectomy; Neoplasm Proteins; Neoplasms, Multiple Primary; Neoplastic Syndromes, Hereditary; Oncogenes; Ovarian Neoplasms; Ovariectomy; Phenotype; Raloxifene Hydrochloride; Retrospective Studies; Risk; Tamoxifen; Transcription Factors

2000

[Cardiovascular effects of SERM].

Clinical calcium, 2004, Volume: 14, Issue:10

Topics: Apoptosis; Cell Cycle; Cyclin D1; Endothelium, Vascular; Estrogens; Gene Expression; Humans; Muscle, Smooth, Vascular; Myocardial Ischemia; Nitric Oxide; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Vasodilation

2004

Other Studies

4 other study(ies) available for raloxifene hydrochloride and cyclin d1

Article	Year
Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. The Journal of endocrinology, 2003, Volume: 178, Issue:2 Topics: Animals; Aorta; Blotting, Western; Cell Division; Cell Line; Cells, Cultured; Cyclin D1; Depression, Chemical; Estradiol; Estrogen Receptor alpha; Flow Cytometry; Fulvestrant; G1 Phase; Humans; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; Selective Estrogen Receptor Modulators; Transfection	2003
[The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhonghua yi xue za zhi, 2008, Jan-22, Volume: 88, Issue:4 Topics: Apoptosis; Blotting, Western; Bone Density Conservation Agents; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Inhibitors; Flavonoids; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyridines; Raloxifene Hydrochloride; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction	2008
Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation. Hormones & cancer, 2013, Volume: 4, Issue:1 Topics: Apoptosis; Carcinoma, Transitional Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Humans; Immediate-Early Proteins; MCF-7 Cells; Poly(ADP-ribose) Polymerases; Raloxifene Hydrochloride; S-Phase Kinase-Associated Proteins; Tamoxifen; Tumor Suppressor Proteins; Urinary Bladder Neoplasms	2013
Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene. Experimental cell research, 2016, 05-15, Volume: 344, Issue:1 Topics: Axin Protein; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gonanes; Humans; Immunoblotting; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Raloxifene Hydrochloride; Real-Time Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Telomerase; Transcription, Genetic; Transforming Growth Factor beta	2016